Project Grant R16HL178696
Award Date
9/10/24
Completion Date
7/31/28
Dollars Obligated
$375K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Durham, NC 27707, USA
Similar Awards
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $2,545,216 Project Grant under CFDA 93.837 (Cardiovascular Diseases Research) to the University of Wisconsin - Madison to conduct a longitudinal study on the effects of long-term e-cigarette use on cardiovascular and pulmonary health. The study will recruit 400 long-term e-cigarette users and 200 non-users to undergo comprehensive biomarker assessments over 36 months, evaluating measures such as arterial structure, sympathetic...
This Project Grant award from the National Institutes of Health's Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) provides $549,555.45 to The Trustees of the University of Pennsylvania to investigate the exposure and respiratory health effects of chemical constituents from electronic cigarette (e-cigarette) use among young adults. The project aims to: 1) evaluate the relationship between e-cigarette use and exposure to metals and aldehydes, 2) assess...
This Project Grant awarded by the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $900,000 to Louisiana State University to investigate the impact of prenatal exposure to copper from electronic nicotine delivery system (ENDS) aerosols on the neonatal pulmonary immune system and development of IL-10-mediated allergic asthma. The research aims to determine the transplacental passage of copper, the role of IL-10 and its methylation status, and...
The federal Project Grant award R01HL179076 from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $355,000.00 to the Palo Alto Veterans Institute for Research (Pavir) from May 15, 2025 to Feb 28, 2029. The grant supports research to examine the epigenetic impacts of e-cigarette use and nicotine exposure on the transgenerational risk of abdominal aortic aneurysm (AAA). The key objectives are to determine how e-cigarette vapor and nicotine...
This $3,230,000 Project Grant awarded by the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) supports research to investigate the cardiovascular effects of dual use of tobacco and nicotine delivery products, such as cigarettes and e-cigarettes. The project, awarded to the University of California, San Francisco (UCSF), aims to: (1) understand the cardiovascular health effects of...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Trustees of Indiana University, doing business as Indiana University Indianapolis (IU Indianapolis). The $230,618 grant, awarded on January 8, 2025, will fund research to identify a novel high molecular weight compound generated from vaping vitamin E acetate (A-T-acetate) that may be linked to E-cigarette or Vaping Associated...
This Project Grant award, valued at $282,862 and awarded by the National Science Foundation (NSF) under the Integrative Activities program (CFDA 47.083), supports research at Oklahoma State University (OSU) to investigate the health risks of e-cigarettes and cannabis aerosols, particularly those containing unregulated synthetic cooling agents. The key objectives of this 2-year project are to: (1) quantify exposure and toxicity levels of various vaping aerosol components, (2) assess variability...
This Project Grant award, funded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, supports a research project to identify key features of e-cigarette-related social media posts that are associated with high user engagement. The goal is to provide guidance for designing effective vaping prevention messages for future public health campaigns to help communicate the risks of e-cigarette use and prevent youth and young adult initiation...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $1,854,091.28 to Texas A&M University System Health Science Center to conduct research on the impact of paternal exposure to electronic nicotine delivery systems (ENDS) on thrombogenesis and cardiovascular health. The research aims to investigate the mechanistic effects of paternal ENDS exposure on normal hemostasis, platelet function, coagulation markers, and...
This Project Grant award of $720,855, provided by the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program, will fund research to investigate the impact of in utero exposures to electronic nicotine delivery system (ENDS) aerosols on children's respiratory health. The key products and services to be delivered under this award include: Experiments to assess the deposition of ENDS aerosols in human airways and associated health risks...